Short answer
Definium Therapeutics, Inc. (DFTX) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Annual meeting quorum established with 78.7M shares represented, approximately 72% of voting shares.
Definium Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Annual meeting quorum established with 78.7M shares represented, approximately 72% of voting shares
- All seven director nominees elected through the 2027 Annual Meeting
- KPMG LLP auditor appointment approved with 78.6M votes for
- Equity Plan Amendment approved with 58.1M votes for, 4.7M against
Other items in this filing:
- Item 5.02: Departure/Election of Directors or Officers
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definium Therapeutics, Inc. 8-K filings
Get the next DFTX 8-K as it lands
Follow DFTX for push alerts, or ask the research agent what this filing means.